Driving Innovation
for Life Sciences in Europe


The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) is Europe’s trade body that gives a bigger voice to small and mid-sized innovative companies working in the field of biopharmaceuticals and medical technologies. Through its members, EUCOPE represents 2600+ innovative companies that are researching, designing, developing, supplying, manufacturing, and deploying the next generation of pharmaceutical innovation and therapeutic solutions around the continent.

Based in Brussels, Belgium, EUCOPE’s commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve, and healthcare systems overall. Read more…

Upcoming Events


13. October 2022

RareConversations Conference

Alexion is happy to invite you to their annual conference, which will build on the conclusions of previous events in order to develop recommendations on the way forward for the rare disease ecosystem. The event will reflect on several aspects that may be included in… read more


26. October 2022 — Register Here

Nordic Growth Summit

Back Bay Life Science Advisors together with the Innovation Centre Denmark is pleased to welcome you to the Nordic Growth Summit, a day of international collaboration. The Nordic Growth Summit is a gathering of biopharma, medtech and healthtech organizations leading Scandinavian life sciences and collectively… read more


8. November 2022 to 9. November 2022

8th Annual World Cancer Series: Europe 2022

The 8th Annual World Cancer Series Europe will convene a wide range of stakeholders critical to effective cancer control: policymakers, healthcare professionals and providers, regulators, payers, investors, industry and of course patient groups. The focus of this year’s conference is ”innovation, equity and excellence.” The… read more


14. November 2022 to 17. November 2022 — Register Here

World Orphan Drug Conference EU

The World Orphan Drug Congress is an award-winning event with an exhibition that has grown to become the largest and most established orphan drugs & rare diseases meeting of its kind across the globe. Now in its 13th annual edition, the World Orphan Drug Congress… read more


29. November 2022 to 30. November 2022

DIA-EUCOPE Innovative Therapies in Europe Workshop and the pre-conference tutorial: Transforming Value into Access during Payer Negotiations 

EUCOPE is co-hosting a pre-conference tutorial and workshop at the IDA Innovative Therapies in Europe event. Over two days, key stakeholders and participants will discuss and share practical experiences on: how to create a negotiation pathway to increase the likelihood of reaching an agreement on… read more


29. November 2022

Regulatory Working Group Meeting

News & Updates

EUCOPE co-signs letter calling for a European Action Plan on Rare Diseases

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) joined the 57 partner organisations that co-signed EURORDIS’ letter calling on the European Commission to take forward the conclusions of the conference for a European Action Plan on Rare Diseases. EUCOPE is a strong champion for a holistic… read more

On the update of the Blood, Tissues and Cell (BTC) Legislation

On July 14, the European Commission formally published its proposal updating the BTC legislation. Under the Commission’s proposal, the two Directives (2002/98/EC, for blood and blood components and 2004/23/EC, for tissues and cells) will be rolled into one Regulation, the SoHO (Substances of Human Origin) Regulation…. read more

EUCOPE joins the Joint Industrial Cooperation Forum of HERA

EUCOPE has been selected to join the Joint Industrial Cooperation Forum (JICF), a sub-group of the Health Emergency Preparedness and Response Advisory (HERA) Forum. The first meeting of the JICF took place on 13 July where EUCOPE, along with other industrial organizations and national representatives,… read more

🎙️Sounds of Science – Episode 7 on Unmet Medical Needs (UMN)

Sounds of Science Podcast – Episode 7 Unmet Medical Needs (UMN): Towards a new understanding with a focus on underserved areas The topic of unmet medical needs (UMN) is quite high up on the agenda in European health policy these days. Recent literature has identified… read more

Job Opening: Policy Intern

We’re looking to recruit a talented Policy Intern with some knowledge of the EU institutions, its processes and policies. About you You are educated to a degree level in a relevant field ( e.g. Political Science, Law, Communication, Economics) and are looking for your first… read more

SURVEY: Medical Device Regulation (MDR) for European Innovators

The objective of this survey is to capture the consequences of the Medical Devices Regulation (MDR) on innovative European companies, including those that have received significant government money. We expect that a contradiction could emerge between the massive investment done by the EU and Member… read more

Partnerships in Focus: Q&A with FIPRA’s Sheela Upadhyaya

At EUCOPE, our commitment is to lead and engage in partnerships spanning the entire medicine lifecycle to find actionable solutions that benefit our members, the patients they serve and healthcare systems overall. Through our Partnerships in Focus series, we’ll be highlighting different associates that we… read more

Six new members join the EUCOPE network

The European Confederation of Pharmaceuticals Entrepreneurs (EUCOPE) announced the joining of six (6) new members at its quarterly Members Meeting on June 22nd following Board approval. The new members joining EUCOPE network are: Amylyx Pharmaceuticals, Arnold&Porter, Bavarian Nordic, Laboratoire Cevidra and Urovant Sciences. During the… read more

Event Recap: ‘The Future of Rare Diseases in Europe & Czech Republic’ Webinar

The European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) hosted a virtual roundtable on the future of rare diseases in Europe and the Czech Republic on Monday, 20 June 2022. With the Czech Republic holding the rotating presidency of the Council of the European Union from July… read more

EUCOPE Member Spotlight: Q&A with Alnylam

Every month, EUCOPE spotlights a member company and the great work they’re doing to advance the life sciences industry and drive innovation to serve patients better. In June, we spoke with Julien Patris, Head of Policy – International Markets at Alnylam Pharmaceuticals. Julien Patris is Country… read more

Interested in becoming a member?

EUCOPE gives voice to small to medium-sized innovative companies active in the field of pharmaceuticals, biotechnologies, and medical technologies at the European level. Learn more about the benefits of membership with EUCOPE.

Benefits of membership